Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double‐blind, and placebo‐controlled study-Reference-Cited by-同舟云学术

Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double‐blind, and placebo‐controlled study

Published:2022-03-17 Issue:6 Volume:24 Page:1105-1113
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Lee Minyoung¹^ORCID,Lee Woo‐je²,Kim Jae Hyeon³,Lee Byung‐Wan¹^ORCID

Affiliation:

1. Department of Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea

2. Department of Internal Medicine, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

3. Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea

Funder

Handok Pharmaceuticals

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14679

Reference28 articles.

1. 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association

2. Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease

3. Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel

4. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021

5. Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of teneligliptin in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis;Frontiers in Endocrinology;2023-12-18

2. Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes;Journal of Endocrinological Investigation;2023-01-09

3. Potential approaches using teneligliptin for the treatment of type 2 diabetes mellitus: current status and future prospects;Expert Review of Clinical Pharmacology;2023-01-02

4. Updates of incretin‐related drugs for the treatment of type 2 diabetes;Journal of Diabetes Investigation;2022-11-14